BCV
IRWD icon

Banque Cantonale Vaudoise’s Ironwood Pharmaceuticals IRWD Stock Holding History

Banque Cantonale Vaudoise’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,609
Closed -$50K – 886
2024
Q2 		$50K Buy
7,609
+424
+6% +$3K ﹤0.01% 803
2024
Q1 		$63K Buy
7,185
+660
+10% +$8.01K ﹤0.01% 746
2023
Q4 		$75K Hold
6,525
– – ﹤0.01% 733
2023
Q3 		$63K Hold
6,525
– – ﹤0.01% 934
2023
Q2 		$69K Buy
6,525
+1,460
+29% +$15.7K ﹤0.01% 923
2023
Q1 		$53K Hold
5,065
– – ﹤0.01% 949
2022
Q4 		$63K Hold
5,065
– – ﹤0.01% 922
2022
Q3 		$52K Hold
5,065
– – ﹤0.01% 981
2022
Q2 		$58K Buy
+5,065
New +$59.7K ﹤0.01% 974

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Banque Cantonale Vaudoise's IRWD Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 7,609 shares — an estimated $50K sold.

Banque Cantonale Vaudoise first reported a position in IRWD in Q2 2022 and held it in 9 quarters. The position peaked at $75K in Q4 2023. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • Banque Cantonale Vaudoise reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 7,609 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $50K.
  • Banque Cantonale Vaudoise first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 9 quarters.
  • Banque Cantonale Vaudoise's Ironwood Pharmaceuticals position peaked at $75K in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.